Skip to content

Biohaven BHVN Business Segments — G&A Share-based compensation expense

Similar metrics at other companies

Veradermics
 logo
MANEReportable Segment — General and administrative, personnel expenses (including share-based compensation)
$4.33M+936%
Olaplex Holdings, Inc. logo
OLPXReportable Segment — Share-based compensation expense
$3.52M+20.5%
Capricor Therapeutics logo
CAPRSingle Reportable — General And Administrative Expense Share Based Compensation Expense
$2.79M-7.0%
Opendoor Technologies Inc logo
OPENReportable Segment — Share-based compensation expense
$105M+650%
Logitech International logo
LOGIReportable Segment — Total share-based compensation expense
$25.82M+86.5%
Mirum Pharmaceuticals, Inc. logo
MIRMReportable Segment — General and administrative expenses (excluding stock-based compensation)
$19.18M+64.2%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept bhvn:GeneralAndAdministrativeExpenseShareBasedCompensation.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's business segments — g&a share-based compensation expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's business segments — G&A share-based compensation expense?
Biohaven (BHVN) reported business segments — G&A share-based compensation expense of $9.81M in Q1 2026.
How has Biohaven's business segments — G&A share-based compensation expense changed year-over-year?
Biohaven's business segments — G&A share-based compensation expense decreased by 45.0% year-over-year, from $17.83M to $9.81M.
What is the long-term trend for Biohaven's business segments — G&A share-based compensation expense?
Over 3 years (2022 to 2025), Biohaven's business segments — G&A share-based compensation expense has grown at a -20.0% compound annual growth rate (CAGR), from $77.18M to $39.58M.
What does business segments — G&A share-based compensation expense mean?
Reflects the non-cash expense related to equity compensation for administrative and general personnel. This metric helps investors evaluate the impact of stock-based incentive programs on the company's administrative cost structure. It provides transparency into how the company rewards its non-scientific workforce.